Deerfield Healthcare Innovations Fund, L.P.
SEC-identified person · CIK 1646981 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Parabilis Medicines, Inc. PBLS | Officer | filed 2026–2026 |
| Zafgen, INC. ZFGN | Director | filed 2020–2026 |
| Nuvalent, Inc. NUVL | Director | filed 2021–2025 |
| Oncorus, Inc. ONCR | Director | filed 2020–2022 |
| Mirum Pharmaceuticals, Inc. MIRM | Officer | filed 2019–2022 |
| Graybug Vision, INC. GRAY | Officer | filed 2020–2020 |
| Q32 Bio Inc. QTTB | Director | filed 2018–2020 |
| Editas Medicine, Inc. EDIT | Officer | filed 2016–2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.